PT1495328E - Um marcador para medir cirrose hepática - Google Patents

Um marcador para medir cirrose hepática Download PDF

Info

Publication number
PT1495328E
PT1495328E PT37187739T PT03718773T PT1495328E PT 1495328 E PT1495328 E PT 1495328E PT 37187739 T PT37187739 T PT 37187739T PT 03718773 T PT03718773 T PT 03718773T PT 1495328 E PT1495328 E PT 1495328E
Authority
PT
Portugal
Prior art keywords
marker
liver cirrhosis
measuring liver
measuring
cirrhosis
Prior art date
Application number
PT37187739T
Other languages
English (en)
Inventor
Nico Luc Marc Callewaert
Roland Henri Contreras
Original Assignee
Vlaams Interuniv Inst Biotech
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech, Univ Gent filed Critical Vlaams Interuniv Inst Biotech
Publication of PT1495328E publication Critical patent/PT1495328E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
PT37187739T 2002-04-16 2003-04-16 Um marcador para medir cirrose hepática PT1495328E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02076501 2002-04-16

Publications (1)

Publication Number Publication Date
PT1495328E true PT1495328E (pt) 2014-09-09

Family

ID=29225675

Family Applications (1)

Application Number Title Priority Date Filing Date
PT37187739T PT1495328E (pt) 2002-04-16 2003-04-16 Um marcador para medir cirrose hepática

Country Status (8)

Country Link
US (1) US7335512B2 (pt)
EP (1) EP1495328B1 (pt)
CN (1) CN1662817B (pt)
AU (1) AU2003222825A1 (pt)
CA (1) CA2482686C (pt)
ES (1) ES2498369T3 (pt)
PT (1) PT1495328E (pt)
WO (1) WO2003087833A2 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523330A (ja) 2000-02-04 2003-08-05 チルドレンズ・ホスピタル・リサーチ・ファウンデイション アテローム性動脈硬化症および関連疾患のための脂質加水分解治療
ES2498369T3 (es) 2002-04-16 2014-09-24 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Un marcador para medir cirrosis hepática
WO2004063753A2 (en) 2003-01-14 2004-07-29 Vib Vzw A serum marker for measuring liver fibrosis
US7670764B2 (en) 2003-10-24 2010-03-02 Prometheus Laboratories Inc. Methods of diagnosing tissue fibrosis
US20060127950A1 (en) 2004-04-15 2006-06-15 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
US20060057638A1 (en) 2004-04-15 2006-03-16 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
CA2589247A1 (en) * 2004-12-01 2006-06-08 Vib Vzm Aging biomarker
US10082512B2 (en) * 2005-05-05 2018-09-25 Drexel University Diagnosis of liver pathology through assessment of protein glycosylation
US8173437B2 (en) * 2005-06-10 2012-05-08 Mannatech, Incorporated Rapid serum sugar biomarker assay of rheumatoid arthritis
WO2007030375A2 (en) * 2005-09-08 2007-03-15 Children's Hospital Medical Center Lysosomal acid lipase therapy for nafld and related diseases
US8512258B2 (en) * 2005-11-11 2013-08-20 Exalenz Bioscience Ltd. Breath test device and method
JP2010529470A (ja) * 2007-06-14 2010-08-26 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） 早期段階肝臓癌の検出のための診断試験
JPWO2009069776A1 (ja) * 2007-11-30 2011-04-21 国立大学法人北海道大学 糖鎖分析による肝疾患の診断方法
US9110078B2 (en) 2008-04-04 2015-08-18 Drexel University Diagnosis of liver pathology through assessment of anti-gal IgG glycosylation
US9207242B2 (en) * 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
ES2621838T3 (es) * 2008-11-18 2017-07-05 Universite D'angers Método in vitro no invasivo para la cuantificación de lesiones hepáticas
JP5737761B2 (ja) * 2009-09-18 2015-06-17 大学共同利用機関法人自然科学研究機構 肝細胞癌マーカー
LT3205351T (lt) 2010-04-23 2023-07-25 Alexion Pharmaceuticals, Inc. Lizosomų kaupimosi ligos fermentas
PL2977057T3 (pl) 2010-09-09 2020-06-01 Alexion Pharmaceuticals, Inc. Izolowana rekombinowana ludzka lizosomalna N-glikozylowana kwaśna lipaza
CN102175839B (zh) * 2010-12-23 2013-08-14 中国人民解放军第二军医大学东方肝胆外科医院 IgG核心岩藻糖基化水平检测方法及其应用
US9036883B2 (en) * 2011-01-10 2015-05-19 The Regents Of The University Of Michigan System and methods for detecting liver disease
EP2675472A4 (en) 2011-02-15 2014-09-17 Synageva Biopharma Corp METHOD FOR THE TREATMENT OF LACK OF LYSOSOMAL SAURER LIPASE
CN102565318B (zh) * 2012-01-11 2014-08-06 陈翠英 一种肝癌监测、分期以及预后风险评估的试剂及其方法
HRPK20130568B3 (hr) * 2013-06-20 2016-01-29 Genos D.O.O. Postupak analize n-glikana vezanih na imunoglobulin g iz krvne plazme ljudi i njegova upotreba
CN108026558B (zh) 2015-07-09 2021-08-17 非营利性组织佛兰芒综合大学生物技术研究所 产生具有改变的n-和o-糖基化模式的糖蛋白的细胞及其方法和用途
WO2017032888A1 (en) * 2015-08-26 2017-03-02 Vib Vzw Means and methods for monitoring inflammation
KR102632490B1 (ko) * 2015-10-07 2024-02-02 생귀 바이오 피티와이. 엘티디 혈액 제제 및 프로파일링
EP3393482A4 (en) 2015-12-22 2019-08-21 Sangui Bio Pty. Ltd THERAPEUTIC PROCEDURES USING ERYTHROCYTES
JP7007361B2 (ja) 2016-08-01 2022-01-24 センター ホスピタリア ユニバーシタイア ダンガース 複数標的線維症検査
CN109765378B (zh) * 2016-08-31 2022-06-03 鲁凤民 一种新的肝硬化或肝纤维化标志物
US11693006B2 (en) 2016-12-20 2023-07-04 Sangui Bio Pty. Ltd Blood profiling with protease inhibitors
CN109490548A (zh) * 2018-12-29 2019-03-19 江苏先思达生物科技有限公司 一种肝硬化检测试剂及其在肝硬化检测中的应用
CN112782297A (zh) * 2020-12-24 2021-05-11 郭继生 一种肝硬化相关生物标志物及其筛选方法和应用
AU2022318574B2 (en) 2021-07-30 2024-03-21 Helaina, Inc. Methods and compositions for protein synthesis and secretion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2613085B2 (ja) * 1987-11-19 1997-05-21 寳酒造 株式会社 Ｌ−フコース代謝異常を伴う疾病の検出方法
JPH04282456A (ja) * 1991-03-11 1992-10-07 Takara Shuzo Co Ltd アルコール性肝硬変の検出方法
AU3144993A (en) * 1991-11-21 1993-06-15 Glyko, Inc. Fluorophore-assisted therapeutic drug monitoring
CN1045820C (zh) * 1993-11-18 1999-10-20 重庆市肿瘤研究所 一种用于测定人ⅲ型前胶原的试剂盒及其测定方法
JP3537535B2 (ja) * 1994-07-14 2004-06-14 株式会社中埜酢店 免疫グロブリンｇ結合糖鎖構造に基づく臨床検査方法
WO2001092890A1 (en) * 2000-05-26 2001-12-06 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method for the analysis of picomole amounts of carbohydrates
ES2498369T3 (es) 2002-04-16 2014-09-24 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Un marcador para medir cirrosis hepática

Also Published As

Publication number Publication date
AU2003222825A1 (en) 2003-10-27
CA2482686A1 (en) 2003-10-23
US7335512B2 (en) 2008-02-26
WO2003087833A2 (en) 2003-10-23
CA2482686C (en) 2012-04-03
CN1662817B (zh) 2012-06-27
EP1495328B1 (en) 2014-06-18
CN1662817A (zh) 2005-08-31
US20050112691A1 (en) 2005-05-26
EP1495328A2 (en) 2005-01-12
AU2003222825A8 (en) 2003-10-27
WO2003087833A3 (en) 2004-05-06
ES2498369T3 (es) 2014-09-24

Similar Documents

Publication Publication Date Title
AU2003222825A8 (en) A marker for measuring liver cirrhosis
PT1583968E (pt) Um marcador sérico para medição da fibrose hepática
AU2003277379A8 (en) Enhancing the accuracy of a location estimate
GB2391292B (en) Electronic grip-frame for a paintball marker
IL165883A0 (en) Marker genes for determining renal toxicity
GB2405486B (en) A digital multi-meter
GB0207107D0 (en) Turf image marker
TWI319515B (en) A resist pattern-improving material
EP1526865A4 (en) COMPOUNDS FOR TARGETING HEPATIC CELLS
GB2390469B (en) A magnetic detecting element
EP1580600A4 (en) RESIST COMPOSITION
GB2406644B (en) Viral marker
GB2409740B (en) A measurement interface
AU2003201655A8 (en) Apoe genotype as a prognostic marker for hepatitis
AU2003251691A8 (en) Kit for a wall-finishing board
AU2003263718A1 (en) Register mark
IL148158A0 (en) Marker for sign
AU2003261166A8 (en) Liver tumor marker sequences
AU2003205530A8 (en) Sleeve for a score-card
GB2397377B (en) A Surveying Tool
TW581001U (en) A board for putting things
AU2003293232A8 (en) Marking film
TW567945U (en) Mark structure for fastening tool
GB0227000D0 (en) Measuring tape
TW553382U (en) A tape measure